Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 47 out of 100. Digital health tools

Topic: Amyloid, tau and blood-test diagnosis

Alzheimer's disease is the most common form of dementia and is a serious health problem. The disease is expected to increase further in the upcoming years with the increase of the elderly population. Developing new treatments and diagnostic methods is getting more important. In this study, we focused on the early diagnosis of dementia in Alzheimer's disease via analysis of neuroimages. We analyzed the data diagnosed by the Alzheimer's Disease Neuroimaging Initiative (ADNI) protocol. The analyzed data were T1-weighted magnetic resonance images of 159 patients with Alzheimer's disease, 217 patients with mild cognitive impairment and 109 cognitively healthy older people. In this study, we propose that the volumetric reduction in the hippocampus is the most important indicator of Alzheimer's disease. There is not much research about the relationship between the volumetric reduction in the hippocampus and Alzheimer's disease. This volume information was calculated through semi-automatic segmentation software ITK-SNAP and a data set was created based on age, gender, diagnosis, and right and left hippocampal volume values. The diagnosis via hippocampal volume information was made by using machine learning techniques. By using this approach, we conclude that brain MRIs can be used to distinguish the patients with Alzheimer's Disease (AD), Mild Cognitive Impairment (MCI) and Cognitive Normal (CN) from each other; while most of the studies were only able to distinguish AD from CN. Our results have revealed that our approach improves the performance of the computer-aided diagnosis of Alzheimer's disease.

Key findings

Why it matters

This study used machine learning on MRI scans from 485 people and found that hippocampus volume can help distinguish Alzheimer's disease, mild cognitive impairment, and cognitively normal people from each other. It is about improving computer-aided diagnosis, not about treating, curing or preventing Alzheimer's disease.

Study details

How this study scored 47/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 2 of 5; Sample size 2 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 5 of 7; Citations per year 3 of 5; Impact for its field and year 4 of 6; Cited by studies here 1 of 6; Still being cited 3 of 4; Senior author's track record 1 of 4; Institution's track record 0 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 0 of 2. Total 47 of 100.47 of 100 points earned53 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomised / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Journal of neuroscience methods)
Journal's citation record 2 / 4 Journal of Neuroscience Methods: journal h-index 227 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 2 / 5 2020 — within 10 year(s) of the newest study here
Sample size 2 / 4 159 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 5 / 7 Cited 134 times (OpenAlex, 2026-10-10)
Citations per year 3 / 5 16.8 citations a year over 8 year(s) since 2020
Impact for its field and year 4 / 6 Cited 9.6× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 1 / 6 Cited by 1 other studies in this library
Still being cited 3 / 4 Cited 74 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Mahmut Öztürk: h-index 8 (OpenAlex, whole career)
Institution's track record 0 / 3 Istanbul University: institution h-index 441 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 2 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 32126274)
Free to read 0 / 2 Behind a paywall — scores zero
Total 47 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Uysal, G., & Ozturk, M. (2020). Hippocampal atrophy based Alzheimer's disease diagnosis via machine learning methods. Journal of neuroscience methods. https://doi.org/10.1016/j.jneumeth.2020.108669

Vancouver

Uysal G, Ozturk M. Hippocampal atrophy based Alzheimer's disease diagnosis via machine learning methods. Journal of neuroscience methods. 2020. doi:10.1016/j.jneumeth.2020.108669. PMID: 32126274.

BibTeX

@article{uysal2020-32126274,
  author  = {Uysal, G. and Ozturk, M.},
  title   = {{Hippocampal atrophy based Alzheimer's disease diagnosis via machine learning methods}},
  journal = {Journal of neuroscience methods},
  year    = {2020},
  doi     = {10.1016/j.jneumeth.2020.108669},
  pmid    = {32126274},
  url     = {https://doi.org/10.1016/j.jneumeth.2020.108669}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here.

Later studies that cite this one

1 study in the alzhub library lists this one in its references.

Related studies in Digital health tools

Also tagged “classification”

835 studies in the library carry the topic tag “classification”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 835 tagged studies.

Similar studies

More on Digital health tools

See all studies in Digital health tools →